Next Article in Journal
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast Cancer
Next Article in Special Issue
T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
Previous Article in Journal
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176
Previous Article in Special Issue
Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia
 
 
Editorial

Article Versions Notes

Cancers 2021, 13(14), 3625; https://doi.org/10.3390/cancers13143625
Action Date Notes Link
article xml file uploaded 20 July 2021 11:23 CEST Original file -
article xml uploaded. 20 July 2021 11:23 CEST Update -
article pdf uploaded. 20 July 2021 11:23 CEST Version of Record https://www.mdpi.com/2072-6694/13/14/3625/pdf-vor
article html file updated 20 July 2021 11:24 CEST Original file -
article xml file uploaded 22 July 2021 05:24 CEST Update -
article xml uploaded. 22 July 2021 05:24 CEST Update https://www.mdpi.com/2072-6694/13/14/3625/xml
article pdf uploaded. 22 July 2021 05:24 CEST Updated version of record https://www.mdpi.com/2072-6694/13/14/3625/pdf
article html file updated 22 July 2021 05:26 CEST Update -
article html file updated 27 July 2022 05:37 CEST Update https://www.mdpi.com/2072-6694/13/14/3625/html
Back to TopTop